Question to the Department for Science, Innovation & Technology:

To ask the Secretary of State for Science, Innovation and Technology, with reference to the UK’s Modern Industrial Strategy, CP 1337, published on 23 June 2025, what proportion of funding for preclinical infrastructure linked to translational research networks will be allocated to (a) developing non-animal methods of testing and (b) phasing out animal testing.

The Government is committed to supporting non-animal alternatives and will publish a strategy to support their development, validation and adoption. The majority of the £30 million for preclinical infrastructure linked to translational research networks announced in the Industrial Strategy is expected to support alternative methods, however exact allocations are yet to be completed and will be announced in due course.